Complaint also requests INJUNCTION on US sales … Read more…
The EU’s highest court (Court of Justice inLuxembourg) said that stem-cell research involving human embryos can’t be patented. Read more…
The bill that would ease deadlines for seeking a patent-term extension granted to compensate drug makers for the time it takes to get regulatory approval. Read more…
The Court of Appeals for the Federal Circuit, which specializes in patent cases, said that Myriad Genetics was entitled to patents Read more…
The European Patent Office (EPO) will grant on 8/3/11, an iPSC patent to Professor Shinya Yamanaka (Kyoto University). Read more…
Patent protection for stem-cell research methods that involve cells from human embryos (could) breach EU Union law, Read more…
The patenting of human embryonic stem (hES) cells could produce yet another ambiguous controversy concerning science, ethics and legal issues related to stem cell … intellectual property (IP). Read more…
Founder and Director of Research, Henry McCusker enters his tenth (10) year at Scimitar Equity with past experience in sell-side analysis, buy-side management, corporate management and due diligence.
I started this blog to add commentary, update news flow and insightful opinions that are intelligent, fit to print and SEC compliant.